BR112014015204A2 - método para a marcação de alvos intracelulares e extracelulares de leucócitos - Google Patents
método para a marcação de alvos intracelulares e extracelulares de leucócitosInfo
- Publication number
- BR112014015204A2 BR112014015204A2 BR112014015204A BR112014015204A BR112014015204A2 BR 112014015204 A2 BR112014015204 A2 BR 112014015204A2 BR 112014015204 A BR112014015204 A BR 112014015204A BR 112014015204 A BR112014015204 A BR 112014015204A BR 112014015204 A2 BR112014015204 A2 BR 112014015204A2
- Authority
- BR
- Brazil
- Prior art keywords
- intracellular
- extracellular
- marking
- targets
- leukocyte
- Prior art date
Links
- 210000000265 leukocyte Anatomy 0.000 title abstract 6
- 230000003834 intracellular effect Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 239000011230 binding agent Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000805 cytoplasm Anatomy 0.000 abstract 1
- 238000010186 staining Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70514—CD4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Ecology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
resumo patente de invenção: "método para a marcação de alvos intracelulares e extracelulares de leucócitos". a presente invenção refere-se a métodos para a marcação de alvos intracelulares e extracelulares de leucócitos, bem como a kits para a realização dos ditos métodos, pois o manchamento de leucócitos com agentes de ligação, tais como anticorpos monoclonais (mabs), é uma importante tarefa que é rotineiramente realizada tanto em pesquisa básica bem como em uma variedade de aplicações de diagnóstico. muito frequentemente, marcadores extracelulares bem como intracelulares dos leucócitos têm de ser manchados, por exemplo, a fim de identificar um subconjunto particular de leucócitos por marcadores de superfície extracelulares específicos, bem como características funcionais das células por moléculas específicas que estão presentes no citoplasma. 4/4 1/1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11290586.4 | 2011-12-21 | ||
EP11290586.4A EP2607899B1 (en) | 2011-12-21 | 2011-12-21 | Method for labeling intracellular and extracellular targets of leukocytes |
PCT/IB2012/003071 WO2013093642A1 (en) | 2011-12-21 | 2012-12-21 | Method for labeling intracellular and extracellular targets of leukocytes |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112014015204A2 true BR112014015204A2 (pt) | 2017-06-13 |
BR112014015204A8 BR112014015204A8 (pt) | 2017-06-13 |
BR112014015204B1 BR112014015204B1 (pt) | 2021-03-30 |
Family
ID=47563336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014015204-7A BR112014015204B1 (pt) | 2011-12-21 | 2012-12-21 | Método para a marcação de alvos intracelulares e extracelulares de leucócitos |
Country Status (10)
Country | Link |
---|---|
US (3) | US9678073B2 (pt) |
EP (2) | EP2607899B1 (pt) |
JP (1) | JP6053818B2 (pt) |
KR (1) | KR102067742B1 (pt) |
CN (1) | CN104011542B (pt) |
AU (2) | AU2012356324A1 (pt) |
BR (1) | BR112014015204B1 (pt) |
CA (1) | CA2859605C (pt) |
MX (1) | MX352837B (pt) |
WO (1) | WO2013093642A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2607899B1 (en) | 2011-12-21 | 2016-08-10 | Beckman Coulter, Inc. | Method for labeling intracellular and extracellular targets of leukocytes |
CA2936167A1 (en) | 2015-07-15 | 2017-01-15 | Streck, Inc. | Method and device for stabilizing of proteins |
JPWO2017141789A1 (ja) * | 2016-02-19 | 2018-12-13 | コニカミノルタ株式会社 | 血液由来検体の保管方法および希少細胞の判定方法 |
WO2019118355A1 (en) * | 2017-12-12 | 2019-06-20 | 10X Genomics, Inc. | Systems and methods for single cell processing |
WO2020014639A1 (en) | 2018-07-12 | 2020-01-16 | Beckman Coulter, Inc. | Fixable viability dyes and their uses |
CN111807809B (zh) * | 2019-04-10 | 2021-12-28 | 盐城工业职业技术学院 | 一种棕榈纳米纤维-石墨烯-碳纳米管复合气凝胶的制备方法 |
CN113884671A (zh) * | 2021-09-27 | 2022-01-04 | 苏州东岭生物技术有限公司 | 一种流式染色试剂盒及其配置方法和应用方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6179163A (ja) * | 1984-09-26 | 1986-04-22 | Toa Medical Electronics Co Ltd | 血球測定用試薬 |
JP2891302B2 (ja) * | 1990-03-01 | 1999-05-17 | シスメックス株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬 |
WO1992010395A1 (en) * | 1990-12-08 | 1992-06-25 | Maeda Industries, Ltd. | Change gear mechanism for bicycle |
US5422277A (en) * | 1992-03-27 | 1995-06-06 | Ortho Diagnostic Systems Inc. | Cell fixative composition and method of staining cells without destroying the cell surface |
WO1994018828A1 (en) * | 1993-02-25 | 1994-09-01 | Abbott Laboratories | Multipurpose reagent system for rapid lysis of whole blood samples |
US5891734A (en) * | 1994-08-01 | 1999-04-06 | Abbott Laboratories | Method for performing automated analysis |
JP3170176B2 (ja) * | 1995-05-17 | 2001-05-28 | 大塚製薬株式会社 | 薬剤耐性獲得癌細胞の検出方法 |
EP0900367A1 (en) * | 1996-04-12 | 1999-03-10 | Oncor, Inc. | Method and composition for controlling formaldehyde fixation by delayed quenching |
EP1108212B1 (en) * | 1998-08-27 | 2003-10-29 | Mayo Foundation For Medical Education And Research | Methods and materials for diagnosing unstable angina |
US6210969B1 (en) * | 1999-04-28 | 2001-04-03 | Coulter International Corp. | Composition and method for differentiation of basophil and eosinophil subpopulations of leukocytes in blood |
US7354773B2 (en) * | 2003-05-14 | 2008-04-08 | Beckman Coulter, Inc. | Method and apparatus for preparing cell samples for intracellular antigen detection using flow cytometry |
JP2005274425A (ja) * | 2004-03-25 | 2005-10-06 | New Industry Research Organization | Pxプローブを用いたフォスファチジルイノシトール3リン酸の検出方法 |
US20050266503A1 (en) * | 2004-05-24 | 2005-12-01 | Esoterix, Inc. | Simultaneous assay of target and target-drug binding |
US7803523B2 (en) * | 2004-08-27 | 2010-09-28 | University Health Network | Whole blood preparation for cytometric analysis of cell signaling pathways |
US7678578B2 (en) * | 2005-02-07 | 2010-03-16 | Beckman Coulter, Inc. | Cell permeabilization and stabilization reagent and method of use |
WO2006090874A1 (ja) * | 2005-02-25 | 2006-08-31 | Nihon University | 哺乳動物t細胞のサイトカインの分析方法と関連する一切の疾患の評価法と予防・治療の分析 |
US7235404B2 (en) * | 2005-05-04 | 2007-06-26 | Beckman Coulter, Inc. | Cyanide-free lytic reagent composition and method of use for hemoglobin and white blood cell measurement |
TWI333959B (en) * | 2005-08-31 | 2010-12-01 | Academia Sinica | Methods and reagents for the analysis and purification of polysaccharides |
US7625757B2 (en) * | 2006-01-27 | 2009-12-01 | Sysmex Corporation | Reagent for immature leukocyte analysis and reagent kit |
JP4976038B2 (ja) * | 2006-03-29 | 2012-07-18 | シスメックス株式会社 | 血液学的試料の測定方法 |
HU0600578D0 (en) * | 2006-07-13 | 2006-09-28 | Szilak Labor Bioinformatikai E | Nuclear protein transport |
ES2684695T3 (es) * | 2007-06-25 | 2018-10-04 | Sysmex Corporation | Reactivo y kit de reactivos para el análisis de leucocitos primitivos |
WO2009001869A1 (ja) * | 2007-06-25 | 2008-12-31 | Sysmex Corporation | 幼若白血球の分析用試薬及び分析用試薬キット |
GB2455204B (en) * | 2007-11-28 | 2010-07-14 | Smart Tube Inc | Devices, systems and methods for the collection, stimulation, stabilization and analysis of a biological sample |
EP2607899B1 (en) | 2011-12-21 | 2016-08-10 | Beckman Coulter, Inc. | Method for labeling intracellular and extracellular targets of leukocytes |
-
2011
- 2011-12-21 EP EP11290586.4A patent/EP2607899B1/en active Active
- 2011-12-21 EP EP16001447.8A patent/EP3104177B1/en active Active
-
2012
- 2012-12-21 BR BR112014015204-7A patent/BR112014015204B1/pt active IP Right Grant
- 2012-12-21 MX MX2014007284A patent/MX352837B/es active IP Right Grant
- 2012-12-21 JP JP2014548248A patent/JP6053818B2/ja active Active
- 2012-12-21 US US14/366,024 patent/US9678073B2/en active Active
- 2012-12-21 CN CN201280063544.1A patent/CN104011542B/zh active Active
- 2012-12-21 WO PCT/IB2012/003071 patent/WO2013093642A1/en active Application Filing
- 2012-12-21 AU AU2012356324A patent/AU2012356324A1/en not_active Abandoned
- 2012-12-21 CA CA2859605A patent/CA2859605C/en active Active
- 2012-12-21 KR KR1020147016948A patent/KR102067742B1/ko active IP Right Grant
-
2016
- 2016-06-21 US US15/188,856 patent/US11635433B2/en active Active
-
2018
- 2018-10-11 AU AU2018247279A patent/AU2018247279B2/en active Active
-
2023
- 2023-03-21 US US18/124,224 patent/US20230288416A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2018247279B2 (en) | 2020-12-24 |
US9678073B2 (en) | 2017-06-13 |
EP3104177B1 (en) | 2020-11-25 |
AU2012356324A1 (en) | 2014-07-03 |
CA2859605A1 (en) | 2013-06-27 |
US20230288416A1 (en) | 2023-09-14 |
KR102067742B1 (ko) | 2020-01-20 |
US20160299139A1 (en) | 2016-10-13 |
US11635433B2 (en) | 2023-04-25 |
CN104011542B (zh) | 2016-04-27 |
WO2013093642A1 (en) | 2013-06-27 |
KR20140100536A (ko) | 2014-08-14 |
AU2018247279A1 (en) | 2018-11-01 |
EP3104177A1 (en) | 2016-12-14 |
MX2014007284A (es) | 2015-10-29 |
CN104011542A (zh) | 2014-08-27 |
CA2859605C (en) | 2020-07-07 |
MX352837B (es) | 2017-12-11 |
BR112014015204A8 (pt) | 2017-06-13 |
EP2607899B1 (en) | 2016-08-10 |
JP6053818B2 (ja) | 2016-12-27 |
EP2607899A1 (en) | 2013-06-26 |
JP2015500999A (ja) | 2015-01-08 |
US20150010923A1 (en) | 2015-01-08 |
BR112014015204B1 (pt) | 2021-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014015204A8 (pt) | método para a marcação de alvos intracelulares e extracelulares de leucócitos | |
BR112017027498A2 (pt) | anticorpo, ácido nucleico, composto, composição, e, método para tratamento de um paciente com uma doença. | |
AR118722A2 (es) | Proteínas tóxicas para especies de insectos hemípteros | |
BR112015014751A2 (pt) | anticorpos anti-tau humanos | |
AR088513A1 (es) | Inmunoenlazantes dirigidos contra esclerostina | |
BR112019000512A2 (pt) | anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, composição, métodos de tratamento de uma doença, para produzir um anticorpo biespecífico e para detectar se a reticulação entre as células que expressam cd40 e cd137 ocorre em uma amostra, uso de um anticorpo multiespecífico, e, kit | |
NZ709167A (en) | Compositions and methods for diagnosing thyroid tumors | |
BR112018010410A8 (pt) | método para tratar câncer em um sujeito, composição e métodos de aumento do número de células nk e de aumento do número de uma ou mais células positivas para pd-l1 | |
BR112014015152A2 (pt) | métodos e materiais para a avaliação da perda de heterozigosidade | |
BR112014012101A2 (pt) | métodos de tratamento de artrite psoriática (psa) usando os antagonistas de il- 17 e alelos de resposta ou não resposta à psa | |
BR112015022322A2 (pt) | sistemas e métodos para detecção de células com o uso de partículas de transdução projetadas | |
BR112014007382A2 (pt) | anticorpos anti-erbb3 e seus usos | |
MA38308A1 (fr) | Molécules de liaison à l'antigène bispécifiques activant des lymphocytes t | |
BR112014025384A8 (pt) | método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares | |
AR085138A1 (es) | VARIANTES DE Fc Y METODOS PARA SU PRODUCCION | |
ECSP14001249A (es) | Inmunoenlazadores dirigidos contra el tnf | |
AR088941A1 (es) | Anticuerpos anti-fgfr2 y sus usos | |
BR112012008665A2 (pt) | tratamento de câncer | |
AR089393A1 (es) | Composiciones y metodos para anticuerpos que actuan sobre el factor p | |
MX2017000083A (es) | Compuestos de platino, composiciones y usos de estos. | |
BR112014000181A2 (pt) | bloqueamento de anticorpo agr2 e uso dos mesmos | |
BR112017009151A2 (pt) | ensaios para detectar subgrupos imunológicos de célula t e métodos de uso dos mesmos | |
BR112013024148A2 (pt) | dispositivos e métodos para separar partes marcadas magneticamente em uma amostra | |
BR112014032892A2 (pt) | processo de amplificação por rcp e de detecção de pelo menos uma sequência-alvo nucleotídica, dispositivo de amplificação e de detecção rápida de pelo menos uma sequência-alvo nucleotídica e estojo de amplificação por rcp e de detecção de pelo menos uma sequência nucleotídica-alvo | |
BR112014020756A2 (pt) | co-uso de um inibidor da clusterina com um inibidor do egfr para tratar o câncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/12/2012, OBSERVADAS AS CONDICOES LEGAIS. |